ctrlK

ABBV

NYSE

AbbVie Inc.

Health Care, Biotechnology

$246.04

close 7 Aug 2026

+23.86%

52-week change

$434.78B

market cap

$190.75
$267.47

52-week range

Line itemTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Income
Revenue$64.39B$61.16B$56.33B$54.32B$58.05B$56.20B$45.80B$33.27B$32.75B$28.22B$25.64B$22.86B$19.96B$18.79B$18.38B$17.44B
Cost of revenue$18.37B$18.20B$16.90B$20.42B$17.41B$17.45B$15.39B$7.44B$7.72B$7.04B$5.83B$4.50B$4.43B$4.58B$4.51B$4.64B
Gross profit
R&D$9.71B$9.10B$12.79B$7.68B$6.51B$6.92B$6.38B$6.41B$10.33B$5.01B$4.39B$4.29B$3.30B$2.86B$2.78B$2.62B
SG&A$14.67B$14.01B$14.75B$12.87B$15.26B$12.35B$11.30B$6.94B$7.40B$6.30B$5.88B$6.39B$7.72B$5.35B$4.99B$5.89B
Operating income$16.87B$15.08B$9.14B$12.76B$18.12B$17.92B$11.36B$12.98B$6.38B$9.55B$9.34B$7.54B$3.41B$5.66B$5.82B$3.62B
Interest expense$2.92B$2.89B$2.81B$2.22B$2.23B$2.42B$2.45B$1.78B$1.35B$1.15B$1.05B$719.00M$429.00M$299.00M$104.00M
Tax expense$2.38B$2.36B-$570.00M$1.38B$1.63B$1.44B-$1.22B$544.00M-$490.00M$2.42B$1.93B$1.50B$595.00M$1.20B$450.00M$235.00M
Net income$6.31B$4.23B$4.28B$4.86B$11.84B$11.54B$4.62B$7.88B$5.69B$5.31B$5.95B$5.14B$1.77B$4.13B$5.28B$3.43B
Diluted EPS$3.54$2.36$2.39$2.72$6.63$6.45$2.72$5.28$3.66$3.30$3.63$3.13$1.10$2.56$3.35$2.18
Gross margin
Operating margin26.20%24.65%16.22%23.49%31.21%31.89%24.81%39.03%19.49%33.83%36.43%32.97%17.09%30.14%31.65%20.75%
Net margin9.80%6.91%7.59%8.95%20.39%20.54%10.08%23.69%17.36%18.82%23.22%22.50%8.89%21.97%28.70%19.68%

filed 3 Aug 2026